The Lack of Hepatocyte Steatosis in Adult-onset Type II Citrullinemia Patients as Assessed by 7-year Interval Paired Biopsies

Adult-onset type II citrullinemia (CTLN2) is a urea cycle disease characterized by neurological and psychiatric abnormalities associated with hyperammonemia. One of the pathological features of CTLN2 is the presence of hepatocyte steatosis. The condition progresses in almost all CTLN2 patients to nonalcoholic fatty liver disease (NAFLD). We herein report a 74-year-old woman who developed CTLN2 without hepatocyte steatosis. The diagnosis was based on clinical and laboratory findings and confirmed by two liver biopsies conducted within 7 years, as well as by a DNA analysis, which demonstrated mutations in the SLC25A13 gene. We describe a rare CTLN2 case without hepatocyte steatosis in an elderly woman who responded well to a low-carbohydrate diet.

[1]  T. Saheki,et al.  Chronic hepatitis without hepatic steatosis caused by citrin deficiency in a child , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  F. Gonzalez,et al.  Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. , 2015, Biochimica et biophysica acta.

[3]  Y. Kondo,et al.  Three cases of adult‐onset type II citrullinemia treated with different therapies: Efficacy of sodium pyruvate and low‐carbohydrate diet , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  Takeo Kato,et al.  Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia☆ , 2014, Molecular genetics and metabolism reports.

[5]  K. Ishido,et al.  Liver transplantation versus conservative treatment for adult-onset type II citrullinemia: our experience and a review of the literature. , 2013, Transplantation proceedings.

[6]  T. Saheki,et al.  A 73-year-old patient with adult-onset type II citrullinemia successfully treated by sodium pyruvate and arginine , 2013, Clinical Neurology and Neurosurgery.

[7]  S. Horgan,et al.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. , 2011, Radiology.

[8]  T. Saheki,et al.  The characteristics of food intake in patients with type II citrullinemia. , 2011, Journal of nutritional science and vitaminology.

[9]  T. Saheki,et al.  Citrin deficiency and current treatment concepts. , 2010, Molecular genetics and metabolism.

[10]  T. Saheki,et al.  Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. , 2008, Journal of hepatology.

[11]  T. Saheki,et al.  Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency , 2008, Journal of Human Genetics.

[12]  M. Mori,et al.  Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis. , 2006, Journal of hepatology.

[13]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[14]  K. Hsiao,et al.  Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle. , 2004, Molecular genetics and metabolism.

[15]  T. Saheki,et al.  Pathogenesis and Pathophysiology of Citrin (a Mitochondrial Aspartate Glutamate Carrier) Deficiency , 2002, Metabolic brain disease.

[16]  Keiko Kobayashi,et al.  Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD) , 2002, Journal of Human Genetics.

[17]  S. Kawasaki,et al.  Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation , 2001, Journal of neurology, neurosurgery, and psychiatry.

[18]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[19]  S. Scherer,et al.  The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein , 1999, Nature Genetics.

[20]  T. Saheki,et al.  Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult‐onset type II citrullinemia , 1997, Hepatology.